Impact assessment of expanding the utilization of novel antineoplastic drugs for lung cancer treatment on key performance indicators of the Federal project «Cancer control». (2023). Voprosy Onkologii, 69(3), 538-548. https://doi.org/10.37469/0507-3758-2023-69-3-538-548